Dr. Albert Bourla is Chairman and CEO of Pfizer Inc., and author of Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible, a new book that chronicles how Pfizer achieved what many believed to be impossible: the creation of a high efficacy, safe, and producible at-scale mRNA vaccine within a tenth of the expected time.

In a conversation with Martin Reeves, Chairman of the BCG Henderson Institute, Dr. Bourla discusses the critical enablers of Pfizer’s success, both:

• Internally at Pfizer’s mass mobilization effort that enabled the world’s largest pharmaceutical company to act as a nimble startup: complete with bold and risky decisions making, rejection of bureaucracy, and challenging corporate norms at every step of the process, and
• Externally at how Pfizer navigated a charged political environment and complicated web of international bodies to collaborate with partners to develop and deliver the vaccines.

***

About the BCG Henderson Institute

The BCG Henderson Institute is the Boston Consulting Group’s think tank, dedicated to exploring and developing valuable new insights from business, technology, economics, and science by embracing the powerful technology of ideas. The Institute engages leaders in provocative discussion and experimentation to expand the boundaries of business theory and practice and to translate innovative ideas from within and beyond business. For more ideas and inspiration, sign up to receive BHI INSIGHTS, our monthly newsletter, and follow us on LinkedIn and Twitter.